APA (7th ed.) Citation

Han, X., Gu, Y., Li, S., Chen, H., Chen, M., Cai, Q., . . . Huang, J. (2019). Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 145(2), 303-312. https://doi.org/10.1007/s00432-018-2758-6

Chicago Style (17th ed.) Citation

Han, Xue, Yang-kui Gu, Shao-long Li, Hao Chen, Min-shan Chen, Qing-qing Cai, Han-xia Deng, Meng-xuan Zuo, and Jin-hua Huang. "Pre-treatment Serum Levels of Soluble Programmed Cell Death-ligand 1 Predict Prognosis in Patients with Hepatitis B-related Hepatocellular Carcinoma." Journal of Cancer Research and Clinical Oncology 145, no. 2 (2019): 303-312. https://doi.org/10.1007/s00432-018-2758-6.

MLA (9th ed.) Citation

Han, Xue, et al. "Pre-treatment Serum Levels of Soluble Programmed Cell Death-ligand 1 Predict Prognosis in Patients with Hepatitis B-related Hepatocellular Carcinoma." Journal of Cancer Research and Clinical Oncology, vol. 145, no. 2, 2019, pp. 303-312, https://doi.org/10.1007/s00432-018-2758-6.